FACIT and OBIO® partner on women-focused seed capital and entrepreneurship program

March 8, 2024 – On International Women’s Day, FACIT and OBIO® are pleased to announce a new partnership in the Ontario life sciences ecosystem, built on their common goal to drive entrepreneurial and commercialization mandates to address the unmet needs and barriers faced by female entrepreneurial leaders in STEM.

Read More from FACIT and OBIO® partner on women-focused seed capital and entrepreneurship program

Women-led health and biotech companies dominate FACIT’s latest investments

November 20, 2023 – On the globally-recognized Women’s Entrepreneurship Day, FACIT is pleased to announce investments in four breakthrough oncology innovations – all driven by women leaders. November 19th each year is a day to celebrate and showcase women’s contributions to advance communities and to strengthen their empowerment in the entrepreneurial ecosystem to drive economic impact. FACIT’s support of the four ventures, Virano Therapeutics, Hyivy Health, Tenomix Inc., and DTPx Therapeutics are representative of an asset portfolio where over one third are women-led or founded innovations, attracting one third of every dollar invested by FACIT – as much as ten times the average for the venture capital industry.

Read More from Women-led health and biotech companies dominate FACIT’s latest investments

FACIT appoints seasoned life science leaders to its Board of Directors

November 1, 2023 – FACIT is pleased to welcome two new directors to its Board, Dr. Maura Campbell and Dr. Laszlo Radvanyi. Dedicated to commercializing Ontario intellectual property and impacting patients with cancer, both executives bring with them decades of private and public sector leadership experiences.  

Read More from FACIT appoints seasoned life science leaders to its Board of Directors

FACIT and T-CAIREM at the University of Toronto partner to commercialize medical AI

August 2, 2023 – FACIT and T-CAIREM announce partnership to commercialize medical artificial intelligence (AI) innovations. The partners intend to harness both T-CAIREM’s innovative translational research in AI and FACIT’s unique commercialization-venture model to build the next generation of Ontario biotechnology companies. The joint mission will accelerate the benefits of AI research to support patients battling cancer.

Read More from FACIT and T-CAIREM at the University of Toronto partner to commercialize medical AI

New Innovative Cancer Technology Wins 2023 Falcons’ Fortunes Pitch Competition

March 31, 2023 – The winning pitch for the 10th anniversary Falcons’ Fortunes pitch competition and the $100,000 Ernsting Entrepreneurship Award was delivered by Dr. Sumaiyah Rehman, co-founder and CEO of DTPx Therapeutics.

Read More from New Innovative Cancer Technology Wins 2023 Falcons’ Fortunes Pitch Competition

FACIT generates $1.5 billion in follow-on investment

March 29, 2023 – FACIT announced $1.5 billion in follow-on investment attracted to its portfolio of cancer biotechnology start-ups in Ontario, a significant milestone for life science commercialization in Canada.

Read More from FACIT generates $1.5 billion in follow-on investment